跳至主要内容
临床试验/IRCT20201012049000N1
IRCT20201012049000N1招募中未知

ucillia Sericata larval therapy in the treatment of diabetic chronic wounds

Shiraz University of Medical Sciences0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15 years 至 90 years(—)
性别
All

入选标准

  • Diabetic patients (more than 15 years old) with chronic wound that signed the informed consent.

排除标准

  • Consumption of drugs that influence the wound healing.
  • immunosuppress patients like hemophilia and hepatic disease.
  • scares> 5cm
  • patients with osteomyelitis, cellulitis and cancers.
  • patients who needs amputation or flap surgery.
  • Patients with vascular problems that needs surgery.
  • Wet and new wounds.
  • More than one wound.
  • smoker or burger disease
  • Claudication or vascular graft problems.
  • ESR, CRP>+1
  • anticouagulation therapy.
  • wound under pressure.
  • fear of insects.
  • ecxema or skin allergy history.
  • Chemotherapy or radiotherapy history.
  • Any sensitivity to special drug.

研究者

相似试验